THE IMMUNOPEROXIDASE LOCALIZATION OF TUMOR-MARKERS IN OVARIAN-CANCER - THE VALUE OF CEA, EMA, CYTOKERATIN AND DD9

被引:13
作者
HAMMOND, RH
BATES, TD
CLARKE, DG
GRANT, AG
HAINES, AMR
EUSTACE, DLS
HEYDERMAN, E
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMASS HOSP,DEPT GYNAECOL,LONDON SE1 7EH,ENGLAND
[2] ST GEORGE HOSP,DEPT SURG,LONDON SW17 0RE,ENGLAND
[3] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMASS HOSP,DEPT RADIOTHERAPY,LONDON SE1 7EH,ENGLAND
[4] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT HISTOPATHOL,LONDON SE1 7EH,ENGLAND
来源
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1991年 / 98卷 / 01期
关键词
D O I
10.1111/j.1471-0528.1991.tb10315.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Primary tumours from 40 patients with epithelial ovarian cancer, treated at St Thomas's Hospital over a 10-year period, were studied for the immunocytochemical expression of the following tumour markers in formalin-fixed paraffin embedded material: carcinoembryonic antigen (CEA), epithelial membrane antigen (EMA), cytokeratin (CAM 5.2), and DD9. An indirect immunoperoxidase staining technique was used. All of the tumours were positive for EMA and CAM 5.2, and 30% of them were positive for both CEA and DD9. The absence of CEA and DD9 may be of value in differentiating between metastatic abdominal adenocarcinomas of ovarian origin and those of gastrointestinal origin, but no indication of prognosis was obtained using these epithelial markers. The strong and widespread staining of all of the tumours for EMA suggests that this may be a useful marker for detecting metastatic or recurrent disease by immunoscintigraphy.
引用
收藏
页码:73 / 83
页数:11
相关论文
共 54 条
[1]   USE OF IMMUNOHISTOCHEMICAL STAINING PANEL FOR CHARACTERIZATION OF OVARIAN NEOPLASMS [J].
ASHORN, P ;
HELLE, M ;
HELIN, H ;
ASHORN, R ;
KROHN, K .
JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (01) :12-16
[2]   BINDING OF ANTI-EMA, AGF 4-48 AND THE LECTIN UEA-1 TO HUMAN OVARIAN CARCINOMAS - HISTOLOGICAL AND CLINICAL CORRELATIONS [J].
BRADGATE, MG ;
REDMAN, CWE ;
ROLLASON, TP ;
WILLIAMS, A ;
BYRNE, P ;
KELLY, K .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (07) :854-860
[3]  
BURCHELL J, 1983, J IMMUNOL, V131, P508
[4]  
BURTIN P, 1973, J IMMUNOL, V111, P1926
[5]   IMMUNOHISTOCHEMICAL LOCALIZATION OF TUMOR-MARKERS IN EPITHELIAL OVARIAN-CANCER [J].
CASPER, S ;
VANNAGELL, JR ;
POWELL, DF ;
DUBILIER, LD ;
DONALDSON, ES ;
HANSON, MB ;
PAVLIK, EJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (02) :154-158
[6]   CARCINOEMBRYONIC ANTIGEN (CEA) AND CARBOHYDRATE DETERMINANT 19-9 (CA 19-9) LOCALIZATION IN 121 PRIMARY AND METASTATIC OVARIAN-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY WITH THE USE OF MONOCLONAL-ANTIBODIES [J].
CHARPIN, C ;
BHAN, AK ;
ZURAWSKI, VR ;
SCULLY, RE .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1982, 1 (03) :231-245
[7]  
DABBS DJ, 1988, CANCER-AM CANCER SOC, V62, P368, DOI 10.1002/1097-0142(19880715)62:2<368::AID-CNCR2820620223>3.0.CO
[8]  
2-Z
[9]   INTESTINE-ASSOCIATED ANTIGENS IN OVARIAN-TUMORS - AN IMMUNOHISTOLOGICAL STUDY [J].
DEBOER, WGRM ;
MA, J ;
NAYMAN, J .
PATHOLOGY, 1981, 13 (03) :547-555
[10]  
FENOGLIO CM, 1981, DIAGN GYNECOL OBSTET, V3, P291